Ovid Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Ovid Therapeutics's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 74% to $391,695. Profit margin reached -13362%. Total operating expenses were $59,673,159.
Profit Margin
| 2014 | 0 | -446.89K | |
|---|---|---|---|
| 2015 | 0 | -13.16M | |
| 2016 | 0 | -22.41M | |
| 2017 | 0 | -64.80M | |
| 2018 | 0 | -51.97M | |
| 2019 | 0 | -59.25M | |
| 2020 | 12.61M | -80.72M | -639.83% |
| 2021 | 208.38M | 122.83M | 58.95% |
| 2022 | 1.50M | -51.40M | -3420.95% |
| 2023 | 391.69K | -52.33M | -13362.17% |
OVID Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 391.69K | 1.50M | 208.38M | 12.61M | 0 | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 0 | 1.38M | 0 | 0 | 255K | 0 | 80.31K | 0 | 11.77K | 0 |
Gross profit | 391.69K | 121.14K | 208.38M | 12.61M | -255K | 0 | -80.31K | 0 | -11.77K | 0 |
Operating exp. | ||||||||||
Research and development | 28.58M | 24.61M | 46.93M | 63.41M | 42.15M | 33.79M | 49.97M | 9.58M | 6.61M | 105.37K |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 59.67M | 57.05M | 84.17M | 94.04M | 61.40M | 52.93M | 65.00M | 22.53M | 13.19M | 446.89K |
Operating income | -59.28M | -55.54M | 124.20M | -81.43M | -61.40M | -52.93M | -65.00M | -22.53M | -13.19M | -446.89K |
Other income (expenses), net | 6.94M | 1.37M | -45.69K | 395.40K | 948.22K | 951.72K | 201.50K | 120.34K | 30.28K | 0 |
Income before tax | -52.33M | -54.16M | 124.16M | -81.03M | -60.46M | -51.97M | -64.80M | -22.41M | -13.16M | -446.89K |
Income tax expense | 0 | -2.76M | 1.32M | -306.84K | -1.20M | 951.72K | -80.31K | -950 | 0 | 0 |
Net income | -52.33M | -51.40M | 122.83M | -80.72M | -59.25M | -51.97M | -64.80M | -22.41M | -13.16M | -446.89K |
Earnings per share | ||||||||||
Basic EPS | -0.74 | -0.73 | 1.78 | -1.38 | -1.51 | -2.11 | -3.35 | -1.14 | -0.67 | -0.09 |
Diluted EPS | -0.74 | -0.73 | 1.78 | -1.38 | -1.51 | -2.11 | -3.35 | -1.14 | -0.67 | -0.09 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source |